KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Treasury Shares (2016 - 2025)

Merck (MRK) has disclosed Treasury Shares for 17 consecutive years, with $63.0 billion as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 5.05% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, up 5.05% year-over-year, with the annual reading at $1.1 billion for FY2025, 5.05% up from the prior year.
  • Treasury Shares for Q4 2025 was $63.0 billion at Merck, up from $61.8 billion in the prior quarter.
  • The five-year high for Treasury Shares was $63.0 billion in Q4 2025, with the low at $56.5 billion in Q4 2022.
  • Average Treasury Shares over 5 years is $948.0 million, with a median of $1.0 billion recorded in 2021.
  • The sharpest move saw Treasury Shares dropped 1.09% in 2022, then increased 8.05% in 2025.
  • Over 5 years, Treasury Shares stood at $57.1 billion in 2021, then dropped by 1.09% to $56.5 billion in 2022, then rose by 1.7% to $57.4 billion in 2023, then rose by 1.48% to $58.3 billion in 2024, then rose by 8.05% to $63.0 billion in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.1 billion, $1.1 billion, and $1.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.